Adam J. Weisbrod
-
- Renal cell carcinoma treatment 22
-
- MRI in cancer diagnosis 7
- Molecular Biology top 10%
- Renal and related cancers 13
- Rheumatology top 5%
- Surgery top 10%
- Management of metastatic bone disease 4
-
- Pediatric Urology and Nephrology Studies 5
-
- Genetic and Kidney Cyst Diseases 5
-
- Chronic Kidney Disease and Diabetes 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- Grant D. SchmitMatthew R. CallstromA. Nicholas KurupThomas D. AtwellR. Houston ThompsonStephen A. BoorjianBradley C. LeibovichChristine M. Lohse
- Partner nations
- United StatesIreland
In The Last Decade
Adam J. Weisbrod
34 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 59
- Pulmonary and Respiratory Medicine 1.4k
- Radiology, Nuclear Medicine and Imaging 397
- Molecular Biology 952
- Rheumatology 192
- Surgery 532
Countries citing papers authored by Adam J. Weisbrod
This map shows the geographic impact of Adam J. Weisbrod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam J. Weisbrod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam J. Weisbrod more than expected).
Fields of papers citing papers by Adam J. Weisbrod
This network shows the impact of papers produced by Adam J. Weisbrod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam J. Weisbrod. The network helps show where Adam J. Weisbrod may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam J. Weisbrod, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2019 | 19 | |
| 3 | 2019 | 119 | |
| 4 | 2018 | 10 | |
| 5 | 2017 | 43 | |
| 6 | 2017 | 21 | |
| 7 | 2016 | 86 | |
| 8 | 2016 | 12 | |
| 9 | 2015 | 70 | |
| 10 | 2014 | 68 | |
| 11 | 2014 | 23 | |
| 12 | 2014 | 3 | |
| 13 | 2013 | 52 | |
| 14 | 2013 | 7 | |
| 15 | 2013 | 11 | |
| 16 | 2012 | 108 | |
| 17 | 2012 | 34 | |
| 18 | 2012 | 40 | |
| 19 | 2011 | 174 | |
| 20 | 2007 | 13 |
About Adam J. Weisbrod
Adam J. Weisbrod is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Radiology, Nuclear Medicine and Imaging, having authored 34 papers that have together received 1.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (22 papers), Renal and related cancers (13 papers), MRI in cancer diagnosis (7 papers), Pediatric Urology and Nephrology Studies (5 papers), Genetic and Kidney Cyst Diseases (5 papers), Management of metastatic bone disease (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.4k citations), Radiology, Nuclear Medicine and Imaging (397 citations) and Molecular Biology (952 citations). Adam J. Weisbrod has collaborated with scholars based in United States and Ireland. Frequent co-authors include Grant D. Schmit, Matthew R. Callstrom, A. Nicholas Kurup, Thomas D. Atwell, R. Houston Thompson, Stephen A. Boorjian, Bradley C. Leibovich, Christine M. Lohse, Rickey E. Carter and Jonathan M. Morris. Their work appears in journals such as Blood, Cancer Research and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.